An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF

This study has been terminated.
Information provided by InterMune

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Idiopathic Pulmonary Fibrosis
			Pulmonary Fibrosis
			Lung Disease
2		Additional conditions recognized in this trial
			Fibrosis
			Lung Diseases
3		More general conditions related to this trial
			Lung Diseases, Interstitial
			Pathologic Processes
			Respiratory Tract Diseases
4		Interventions listed in this trial
			Interferon gamma-1b
5		Additional drug interventions recognized in this trial
			Interferon Alfa-2b
			Interferon Type II
			Interferon-gamma, Recombinant
			Interferons
6		More general drug interventions related to this trial
			Angiogenesis Inhibitors
			Angiogenesis Modulating Agents
			Anti-Infective Agents
			Antineoplastic Agents
			Antiviral Agents
			Growth Inhibitors
			Growth Substances
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
7		Sponsors listed in this trial
			InterMune